Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Catherine L Clelland"'
Autor:
James D. Clelland, Hannah Hesson, Krista Ramiah, Julia Anderson, Abraham Thengampallil, Ragy R. Girgis, Catherine L. Clelland
Publikováno v:
Translational Psychiatry, Vol 14, Iss 1, Pp 1-6 (2024)
Abstract Individuals at clinical high-risk (CHR) of developing psychosis, as well as patients with recent psychosis onset (RO), experience significant negative symptoms that detrimentally impact daily-life functioning and are associated with poor out
Externí odkaz:
https://doaj.org/article/9a17d057665d402f80ad982054e8b37c
Autor:
Catherine L Clelland, Laura L Read, Laura J Panek, Robert H Nadrich, Carter Bancroft, James D Clelland
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e69082 (2013)
There are currently no biological tests that differentiate patients with bipolar disorder (BPD) from healthy controls. While there is evidence that peripheral gene expression differences between patients and controls can be utilized as biomarkers for
Externí odkaz:
https://doaj.org/article/107583c5ba164a7f884f08811f334eb3
Publikováno v:
BJPsych Open, Vol 8 (2022)
Background During the first wave of the coronavirus disease 2019 (COVID-19) pandemic, patients with confirmed cases in New York State accounted for roughly 25% of total US cases, with psychiatric hospital in-patients at particularly high risk for COV
Externí odkaz:
https://doaj.org/article/140b5a2fb1334853bb92c4fdc2303921
Publikováno v:
BJPsych Open
BackgroundDuring the first wave of the coronavirus disease 2019 (COVID-19) pandemic, patients with confirmed cases in New York State accounted for roughly 25% of total US cases, with psychiatric hospital in-patients at particularly high risk for COVI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::706ee61d5842fbc1df1bc8130f5621b7
http://europepmc.org/articles/PMC8649363
http://europepmc.org/articles/PMC8649363
Autor:
James D. Clelland, Joshua T. Kantrowitz, Catherine L. Clelland, Jeffrey A. Lieberman, Tse Choo
Publikováno v:
Schizophrenia Research. 218:321-323
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4bc7bdd3e369901a7c39a1765745eaa
https://doi.org/10.1016/j.schres.2019.12.039
https://doi.org/10.1016/j.schres.2019.12.039
Autor:
Helen Y. Figueroa, Ismael Santa-Maria, Catherine L. Clelland, Stephanie L. Fowler, Avery M. Runyan, Seiji Shioda, Karen Duff, Natura Myeku, Ari W. Schaler, Eric J. Sydney
Publikováno v:
Sci Transl Med
Accumulation of pathological tau in synapses has been identified as an early event in Alzheimer’s disease (AD) and correlates with cognitive decline in patients with AD. Tau is a cytosolic axonal protein, but under disease conditions, tau accumulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4592613b852703aaed0fa4d06b220617
https://doi.org/10.1126/scitranslmed.aba7394
https://doi.org/10.1126/scitranslmed.aba7394
Publikováno v:
Schizophr Res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5392909e68c950462cc6a060deacdd7
https://pubmed.ncbi.nlm.nih.gov/31230962
https://pubmed.ncbi.nlm.nih.gov/31230962
Autor:
Alfred L. Goldberg, Natura Myeku, Nikolay V. Kukushkin, Wai Haung Yu, Sheina Emrani, Karen Duff, Catherine L. Clelland
Publikováno v:
Nature Medicine. 22:46-53
The ubiquitin proteasome system (UPS) degrades misfolded proteins including those implicated in neurodegenerative diseases. We investigated the effects of tau accumulation on proteasome function in a mouse model of tauopathy and in a cross to a UPS r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3935a715b5c64adff0d10ce3ba4f1aa2
https://doi.org/10.1038/nm.4011
https://doi.org/10.1038/nm.4011
Autor:
Robert H. Nadrich, Angela Kaon, James D. Clelland, Alexandra Kelly, Amit Rajparia, Catherine L. Clelland, Karen Duff, Valerie Drouet, Laura L. Read
Publikováno v:
Schizophrenia Research. 156:15-22
25-Hydroxyvitamin D (25(OH)D) deficits have been associated with schizophrenia susceptibility and supplementation has been recommended for those at-risk. Although the mechanism by which a deficit confers risk is unknown, vitamin D is a potent transcr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ea193b027a5759c6ede1ecd89052675
https://doi.org/10.1016/j.schres.2014.03.017
https://doi.org/10.1016/j.schres.2014.03.017
Autor:
Mathieu Herman, Marc I. Diamond, Gustavo A. Rodriguez, Isle M Bastille, David W. Sanders, Ana Mrejeru, Catherine L. Clelland, Selina Wray, Y Helen Figueroa, Eden Nahmani, Rick A C M Boonen, Hongjun Fu, Kelly Rilett, Sheina Emrani, S. Abid Hussaini, Jessica W. Wu, Casey Cook, Karen Duff
Publikováno v:
Nature Neuroscience, 19(8), 1085
Nature neuroscience
Nature neuroscience
Tau protein can transfer between neurons transneuronally and trans-synaptically, which is thought to explain the progressive spread of tauopathy observed in the brain of patients with Alzheimer's disease. Here we show that physiological tau released
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01d1ee23bbbd440c8740fc05acaf2154
http://hdl.handle.net/1887/95595
http://hdl.handle.net/1887/95595
